Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 0
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| KETOROLAC TROMETHAMINE | KETOROLAC TROMETHAMINE | tablet, oral | 72684-006ANDA |
Compare
Other companies listing ketorolac tromethamine
- Cardinal Health 418, Inc.34 sites · 833 NDC
- Viyash Scientific Limited9 sites · 58 NDC
- Hospira, Inc.7 sites · 332 NDC
- Fresenius Kabi USA, LLC6 sites · 561 NDC
- ONESOURCE SPECIALTY PHARMA LIMITED3 sites · 53 NDC
- PD-Rx Pharmaceuticals Inc.1 site · 828 NDC
- ASCLEMED USA INC. DBA ENOVACHEM1 site · 789 NDC
- Camber Pharmaceuticals, Inc.1 site · 640 NDC
- Direct Rx1 site · 554 NDC
- Professional Compounding Centers of America dba PCCA1 site · 487 NDC
Enquiry
Common questions
- Is ATNAHS PHARMA US LIMITED FDA approved?
- ATNAHS PHARMA US LIMITED holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does ATNAHS PHARMA US LIMITED make?
- 1 product is listed under ATNAHS PHARMA US LIMITED in the openFDA NDC Directory, most often as tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.